Innovative Research Lab
Spotlights
Microfluidic Technology for Accelerated Screening of Anti-Cancer Drugs
New medicines can save and improve lives, but drug discovery is an extremely long and expensive process. One of the top scientists at CityU is developing an integrated system based on his internationally recognised, award-winning biochip technology, with the aim of providing a novel drug-screening tool with greatly reduced drug development time and cost ...
CityU’s new blood test technology for accurate detection of cancer cells
Groundbreaking technology that can accurately perform early screening for cancer cells and effectively monitor disease status has been successfully developed by a biomedical research team at City University of Hong Kong (CityU) ...
CityU scholar bestowed life science award
Professor Michael Yang Mengsu, Yeung Kin Man Chair Professor of Biomedical Sciences and Head of the Department of Biomedical Sciences at City University of Hong Kong (CityU), won the 2016 WuXi PharmaTech Life Science and Chemistry Award for his outstanding contributions in the “Development and clinical applications and commercialisation of biochip technology for cellular and biomolecular analysis” ...
CityU researchers identify a protein that promotes cancer metastasis, providing a new potential treatment target
Cancer metastasis is a major cause of cancer-related death. A research team at City University of Hong Kong (CityU) recently identified a protein that triggers the migration of liver and pancreatic cancer cells and metastasis, and is correlated with shortening the survival time of patients. The research findings were verified by in vitro and in vivo models, supported with clinical data, and are expected to provide a new potential target for cancer therapy ...